<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Quantitative <z:e sem="disease" ids="C0272375" disease_type="Disease or Syndrome" abbrv="">antithrombin deficiency</z:e> constitutes an important risk factor for venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>, <z:hpo ids='HP_0003826'>stillbirth</z:hpo>, and other <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">complications of pregnancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Studies suggest, however, that individuals heterozygous for missense mutations involving the <z:chebi fb="5" ids="28304">heparin</z:chebi>-binding site of antithrombin do not have a significantly increased thrombotic risk </plain></SENT>
<SENT sid="2" pm="."><plain>Owing to the rarity of such mutations, it remains unclear whether any specific <z:chebi fb="5" ids="28304">heparin</z:chebi>-binding site defects might be associated with thrombotic potential </plain></SENT>
<SENT sid="3" pm="."><plain>We report here the case of a pregnant woman with an exceptionally rare Type II <z:chebi fb="5" ids="28304">heparin</z:chebi>-binding site antithrombin variant </plain></SENT>
<SENT sid="4" pm="."><plain>This case highlights the difficult issues that are associated with the management of Type II <z:e sem="disease" ids="C0272375" disease_type="Disease or Syndrome" abbrv="">antithrombin deficiency</z:e> during pregnancy </plain></SENT>
</text></document>